Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice.
about
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesThe endothelin system and its role in acute myocardial infarctionCardiovascular and renal phenotyping of genetically modified mice: a challenge for traditional physiology.Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.Protective effects of Allium sativum against defects of hypercholesterolemia on pregnant rats and their offspringIdentifying novel genes for atherosclerosis through mouse-human comparative genetics.Genetic modifiers of atherosclerosis in miceThe association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults.Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart diseaseThe therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heartEndothelin.Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only miceVasospasm of atherosclerotic coronary arteries precipitates acute ischemic myocardial damage in myocardial infarction-prone strain of the Watanabe heritable hyperlipidemic rabbits.Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouseInfluence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.Engine-operating load influences diesel exhaust composition and cardiopulmonary and immune responsesHemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia.Animal models of atherosclerosis.Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery diseaseHDL signaling and protection against coronary artery atherosclerosis in mice.Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(-/-) mice: a paradox of preserved V'O2max and exercise capacity despite coronary atherosclerosis.ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesisIdentification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.Inflammation and plaque vulnerability.Scavenger Receptor Class B Type 1 Deletion Led to Coronary Atherosclerosis and Ischemic Heart Disease in Low-density Lipoprotein Receptor Knockout Mice on Modified Western-type Diet.Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis.Molecular biology of atherosclerosis.Animal models of coronary heart disease.Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis?AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress.Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic RabbitsEndothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L-arginine-tetrahydrobiopterin and enhanced vasoconstriction by endothelin.Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.Triglycerides impair postischemic recovery in isolated hearts: roles of endothelin-1 and trimetazidine.Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice.Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice.Interaction between endothelial heme oxygenase-2 and endothelin-1 in altered aortic reactivity after hypoxia in rats.Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice.
P2860
Q26822630-306127D1-2653-46A7-8E0A-1A25251AF903Q28263224-2BB71D2E-DFA3-4324-A26E-FA05BD12770DQ30332704-BDF34EAB-9724-41DE-9AFB-1A9EEF8EDF5CQ30942732-DDA27724-2470-4A60-A44A-411B45E9871BQ33951204-57916196-60C7-4703-80F4-F877C60D6845Q34021005-B485F693-93A2-42C8-9C1F-43A7E62D88ABQ34080318-FC21808B-FD47-448F-B8C2-C67CC87BFCCEQ34354255-1EB494E7-DFC5-4452-A5E7-4E8626FEB664Q34359022-2A92E1FF-09D6-4381-AB99-D90F375AC792Q35001002-079A9568-65DC-410A-B085-A2AC9D7F1F00Q35048723-1A614C14-6E0A-4F25-B8ED-E7FA8D3E7F12Q35120667-1B23AA09-9687-47F1-B66E-A4B30A6058FCQ35121259-9A5ED166-61C1-452A-9A38-C3522D36C911Q35146439-FE9C288D-C907-442B-8D6B-E39752AF13CEQ35163535-34F17460-6474-4735-BC91-38A573D251BAQ35603368-BC82D48C-8A28-4D23-9AF0-1C982D9C63D7Q35611327-56E8DA32-13A5-4F16-8D74-E75E0D771B3FQ35644835-1A70E111-7A41-4B47-BA49-C83F2FCE5C32Q35903298-DEB5525A-9314-4F25-A048-89E3C1352640Q36753752-DA90D4FE-0696-468B-8A49-00CFB354A288Q36765386-56FF6B85-8565-4716-B3FD-3E2095183630Q36830291-CB31B8CD-F661-421A-9131-2579641E1307Q36843340-86D5EAED-33F9-4559-9D6A-FDE0101183F8Q37240487-0A76B2B7-CE19-47D4-AB0D-92DA5FFD0510Q37370224-1667CC95-574C-4722-8896-5003DDB93BF8Q37639147-BFD27EA4-24E1-443C-9951-1DBB15A92EE3Q38025388-A19AEFE9-4E0E-46B4-A5B2-C7C942209252Q38125279-3014ACE3-0677-4598-B7EB-78E89DE0DA2AQ38639118-DBF74480-5A40-4842-A3CC-282495793D5AQ38888696-F779A309-7450-44CF-A79D-525B7DFE3BACQ40166461-7C17C251-AB79-4759-80EF-60C6B3944613Q40279611-F3277655-414F-4F6D-B73D-50EFD3289923Q40783940-33B5B5C3-CBE0-4779-A795-717A84F560A9Q42037930-CE5EE853-C710-47E6-8E84-A843E800AB4FQ43026501-8F556448-7BBC-4341-8666-96E8B850AE48Q43713879-4AD24F0D-C889-4491-AE26-D69830A05246Q44805455-D1850008-9895-482F-ADFD-2B68A92730F4Q45067797-3DEB1C70-9D8A-40FC-BF79-23894FA39BB5Q45107973-BADF3ECB-5DFD-4CF2-8185-002EEBA74084Q46141600-1421DB20-81CE-4D59-A46D-6742B1C2CA9B
P2860
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@ast
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@en
type
label
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@ast
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@en
prefLabel
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@ast
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@en
P2093
P2860
P356
P1476
Myocardial infarction mediated ...... in hypercholesterolemic mice.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.12.6920
P407
P577
1999-06-01T00:00:00Z